Total Funding
76
45
Total FundingSeries B raised
Growth Score 76 in past quarter
-15 pts
Heat Score 45 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
24142
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.
Neil Miller: Co-Founder & CEOPast Role: Auspherix, Chief Executive Officer- Paul Thompson: Chief Development OfficerPast Role: MISSION Therapeutics, Chief Scientific Officer
About the Company
NRG Therapeutics is a drug discovery company focused on neurodegenerative diseases. The company builds a pipeline of drug candidates aimed at restoring mitochondrial function. This therapeutic approach is designed to slow or halt the progression of diseases like Parkinson’s and ALS.